Ginkgo Bioworks Holdings (DNA) EPS (Basic) (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) posted EPS (Basic) of -$0.11 for Q1 2026, up 92.47% on a QoQ basis from -$1.46 in Q4 2025, and up 22.26% year-over-year from -$0.09 in Q1 2025.
Ginkgo Bioworks Holdings (DNA) EPS (Basic) (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.11 for Q1 2026.
- Quarterly EPS (Basic) rose 22.26% year-over-year to -$0.11 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.83 (up 46.51% YoY) and the FY2025 annual result came in at -$5.64, up 46.5% from the prior year.
- EPS (Basic) was -$0.11 for Q1 2026 at Ginkgo Bioworks Holdings, up from -$1.46 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.11 in Q1 2026 and bottomed at -$4281.4 in Q1 2023.
- A 5-year average of -$256.61 and a median of -$3.59 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) plunged 29037.74% — and 2024, when it jumped 99.92%.
- Ginkgo Bioworks Holdings' EPS (Basic) stood at -$4.12 in 2022, then fell by 5.62% to -$4.35 in 2023, then soared by 52.42% to -$2.07 in 2024, then climbed by 29.73% to -$1.46 in 2025, then soared by 92.47% to -$0.11 in 2026.
- Business Quant data shows DNA's EPS (Basic) at -$0.11 in Q1 2026, -$1.46 in Q4 2025, and -$1.45 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn | -0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.11 |
| Dec 31, 2025 | -1.46 |
| Sep 30, 2025 | -1.45 |
| Jun 30, 2025 | -1.10 |
| Mar 31, 2025 | -0.14 |
| Dec 31, 2024 | -2.07 |
| Sep 30, 2024 | -1.08 |
| Jun 30, 2024 | -4.23 |
| Mar 31, 2024 | -3.31 |
| Dec 31, 2023 | -4.35 |
| Sep 30, 2023 | -6.21 |
| Jun 30, 2023 | -3.59 |
| Mar 31, 2023 | -4,281.43 |
| Dec 31, 2022 | -4.12 |
| Sep 30, 2022 | -16.44 |
| Jun 30, 2022 | -16.55 |
| Mar 31, 2022 | -14.69 |
| Dec 31, 2021 | -47.21 |
| Sep 30, 2021 | -3.09 |
| Jun 30, 2021 | -1.69 |